Skip to main navigation menu Skip to main content Skip to site footer

Pulmonary sarcoidosis: the typical and atypical

Sarcoidosis pulmonar: lo típico y lo atípico




Section
Topics review

How to Cite
Pulmonary sarcoidosis: the typical and atypical.
rev. colomb. neumol. [Internet]. 2018 May 10 [cited 2024 Nov. 24];29(2):46-61. Disponible en: https://doi.org/10.30789/rcneumologia.v29.n2.2017.267

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Adriana Morales Cárdenas
    María Carolina Pérez
      Jacqueline Mugnier

        Sarcoidosis is a chronic multisystemic disease whose cause is not well understood. Peak incidence occurs among people between 20 and 29 years of age, and the disease has higher prevalences among women and black people than in the general population. The lungs are the most frequently affected organ, accounting for 90% of cases, but only 50% are symptomatic. Diagnosis requires histopathological confirmation, except in patients who have the Löfgren triad. Characteristic histology consists of noncaseating granulomas with giant multinucleated cells. Radiological manifestations of pulmonary disease due to sarcoidosis are extensive. They include typical lymphadenopathy, especially bilateral hilar lymphadenopathy, and right paratracheal lymphadenopathy; parenchymal manifestations including perilymphatic nodules, bilateral perihilar opacities, and changes due to fibrosis; atypical lymphadenopathy including unilateral lymphadenopathy and asymmetric lymphadenopathy; and parenchymal manifestations including alveolar sarcoidosis, lung masses, airway diseases, pleurisy and other manifestations such as mycetoma. Thirty percent of patients have extrapulmonary involvement, most frequently hepatic (40% - 60%). The prognoses for patients with this disease is good, and remission occurs in 66% of patients. The Scadding criteria for chest x-rays is currently used to stage sarcoidosis, but CT scan studies have shown findings such as centrilobular nodules, consolidation, ground glass patterns and thickening of interlobular septa that correlate with reversibility of imaging alterations.

        Article visits 8109 | PDF visits 9565


        Downloads

        Download data is not yet available.
        1. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10):1885-9. DOI: 10.1164/ajrccm.164.10.2104046.
        2. Criado E, Sánchez M, Ramírez J, Arguis P, de Caralt TM, Perea RJ. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics. 2010;30(6):1567-86. DOI: 10.1148/rg.306105512.
        3. Baughman RP, Lower EE, Gibson K. Pulmonary manifestations of sarcoidosis. Presse Med. 2012;41:289-302. DOI: https://doi.org/10.1016/j.lpm.2012.03.019.
        4. Ors F, Gumus S, Aydogan M, Sari S, Verim S, Deniz O. HRCT findings of pulmonary sarcoidosis; relation to pulmonary function tests. Multidiscip Respir Med. 2013;8(1):8. DOI: 10.1186/2049-6958-8-8.
        5. Müller-Quernheim J, Prasse A, Zissel G. Pathogenesis of sarcoidosis. Press Med. 2012;41(6):e275-87. DOI: https://doi.org/10.1016/j.lpm.2012.03.018.
        6. Herráez I, López L. La sarcoidosis torácica. Radiología. 2011;53:434-48. DOI: 10.1016/j.rx.2011.03.010.
        7. Balan A, Hoey ETD, Sheerin F, Lakkaraju A, Chowdhury FU. Multi-technique imaging of sarcoidosis. Clin Radiol. 2010;65:750-60. DOI: 10.1016/j.crad.2010.03.014.
        8. Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of conventional TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Care. 2013;58(4):683-93. DOI: 10.4187/respcare.02101.
        9. de Boer S, Milne DG, Zeng I, Wilsher ML. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? Thorax. 2009;64(5):436-9. DOI: 10.1136/thx.2008.105031.
        10. Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31(4):404-8. DOI: 10.1055/s-00301262207.
        11. Vagal AS, Shipley R, Meyer CA. Radiological manifestations of sarcoidosis. Clin Dermatol. 2007;25(3):312-25. DOI: 10.1016/j.clindermatol.2007.03.009.
        12. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):73655. DOI: 10.1164/ajrccm.160.2.ats4-99.
        13. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. Br Med J. 1961;2:1165-72. DOI: https://doi.org/10.1136/bmj.2.5261.1165.
        14. DeRemee RA. The roentgenographic staging of sarcoidosis. Chest. 1983;83(1):128-33. DOI: https://doi.org/10.1378/chest.83.1.128.
        15. Little B. Sarcoidosis: overview of pulmonary manifestations and imaging. Semin Roentgenol. 2015;50(1):52-64. DOI: 10.1053/j.ro.2014.06.001.
        16. Lynch JP. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med. 2003;24(4):393-418. DOI: 10.1055/s-2003-42375.
        17. Kumazoe H, Matsunaga K, Nagata N, Komori M, Wakamatsu K, Kajiki A, et al. «Reversed halo sign» of highresolution computed tomography in pulmonary sarcoidosis. J Thorac Imaging. 2009;24(1):66-8. DOI: 10.1097/RTI.0b013e318190476f.
        18. Marchiori E, Zanetti G, Hochhegger B, Cameron RT, Loureiro K. Letters to the Editor. Radiographics. 2011;31:892.
        19. Nakatsu M, Hatabu H, Morikawa K, Uematsu H, Ohno Y, Nishimura K, et al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign. AJR Am J Roentgenol. 2002;178:1389-93. DOI: 10.2214/ajr.178.6.1781389.
        20. Harada T, Nabeshima K, Matsumoto T, Akagi T, Fujita M, Watanabe K. Histological findings of the computed tomography in pulmonary sarcoidosis. Eur Respir J. 2009;34:281-3. DOI
        21. Marten K, Rummeny EJ, Engelke C. The CT halo: a new sign in active pulmonary sarcoidosis. Br J Radiol. 2004;77:1042-5. DOI: https://doi.org/10.1259/bjr/29049682.
        22. Battesti JP, Saumon G, Valeyre D, Amouroux J, Pechnick B, Sandron D, et al. Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax. 1982;37:448-52. DOI: http://dx.doi.org/10.1136/thx.37.6.448.
        23. Nishimura K, Itoh H, Kitaichi M, Nagai S, Izumi T. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology. 1993;189:105-9. DOI: https://doi.org/10.1148/radiology.189.1.8372178.
        24. Hours S, Nunes H, Kambouchner M, Uzunhan Y, Brauner MW, Valeyre D, et al. Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis. Medicine (Baltimore). 2008;87(3):142-51. DOI: 10.1097/MD.0b013e3181775a73.
        25. Ross JJ, Katz JD. Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis. 2002;34(12):937-9. DOI
        26. Damuth TE, Bower JS, Cho K, Dantzker DR. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest. 1980;78:888-91. DOI: https://doi.org/10.1378/chest.78.6.888.
        27. Hoffstein V, Ranganathan N, Mullen JB. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis. 1986;134:809-11. DOI
        28. Smith LJ, Lawrence JB, Katzenstein AA. Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci. 1983(1);285:38-44. DOI: https://doi.org/10.1097/00000441-198301000-00004.
        29. Hawtin KE, Roddie ME, Mauri FA, Copley SJ. Pulmonary sarcoidosis: the ‘Great Pretender’. Clin Radiol. 2010;65(8):642-50. DOI: 10.1016/j.crad.2010.03.004.
        30. Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. 2006;61:68-74. DOI: 10.1136/thx.2005.042838.
        31. Mendelson DS, Norton K, Cohen BA, Brown LK, Rabinowitz JG. Bronchial compression: an unusual manifestation of sarcoidosis. J Comput Assist Tomogr. 1983;7:892-4. DOI
        32. Hennebicque AS, Nunes H, Brillet PY, Moulahi H, Valeyre D, Brauner MW. CT findings in severe thoracic sarcoidosis. Eur Radiol. 2005;15(1):23-30. DOI: https://doi.org/10.1007/s00330-004-2480-4.
        33. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J. 1993;6:349-53. DOI
        34. Froudarakis ME, Bouros D, Voloudaki A, Papiris S, Kottakis Y, Constantopoulos SH, et al. Pneumothorax as a first manifestation of sarcoidosis. Chest. 1997;112(1):278-80. DOI: https://doi.org/10.1378/chest.112.1.278.
        35. Wells A. High resolution computed tomography in sarcoidosis: a clinical perspective. Sarcoidosis Vasc Diffuse Lung Dis. 1998;15(2):140-6. DOI
        36. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. Am J Roentgenol.2000;174:1751-7. DOI: 10.2214/ajr.174.6.1741751.
        37. Gezer NS, Başara I, Altay C, Harman M, Rocher L, Karabulut N, et al. Abdominal sarcoidosis: cross-sectional imaging findings. Diagnostic Interv Radiol. 2015;21:111-7. DOI: 10.5152/dir.2014.14210.
        38. Ratner SJ, Fenoglio JJ, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest. 1986;90:528-33. DOI: https://doi.org/10.1378/chest.90.4.528.
        39. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest. 2002;122(6):1895-901. DOI: https://doi.org/10.1378/chest.122.6.1895.
        Sistema OJS 3.4.0.7 - Metabiblioteca |